CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | COX CARRIE SMITH Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2025-01-02 | DeSilva Nishan M Director | Grant or award | +2,600 | 8,766 | ||
| 2025-01-02 | DeSilva Nishan M Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2024-12-26 | Singer Michael Director | Gift | −20,000 | 70,933 | ||
| 2024-12-26 | English Emily SVP, Head of Manufacturing | Option exercise | +7,650 | $3.30 | $25K | 25,923 |
| 2024-12-26 | English Emily SVP, Head of Manufacturing | Option exercise · Stock Option (Right to Buy) | −7,650 | 49,369 | ||
| 2024-12-23 | SPRINGER TIMOTHY A Director | Purchase | +5,181 | $19.00 | $98K | 8,507,895 |
| 2024-12-20 | SPRINGER TIMOTHY A Director | Purchase | +21,800 | $18.94 | $413K | 8,502,714 |
| 2024-12-19 | SPRINGER TIMOTHY A Director | Purchase | +11,303 | $17.39 | $197K | 8,467,009 |
| 2024-12-19 | SPRINGER TIMOTHY A Director | Purchase | +10,529 | $18.35 | $193K | 8,477,538 |
| 2024-12-19 | SPRINGER TIMOTHY A Director | Purchase | +3,376 | $18.93 | $64K | 8,480,914 |
| 2024-12-10 | Kurtoglu Metin Chief Technology Officer | Option exercise | +2,901 | $1.41 | $4K | 53,934 |
| 2024-12-10 | Kurtoglu Metin Chief Technology Officer | Sale | −2,901 | $24.35 | $71K | 51,033 |
| 2024-12-10 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −2,901 | 79,099 | ||
| 2024-12-09 | Kurtoglu Metin Chief Technology Officer | Option exercise | +10,763 | $1.41 | $15K | 61,796 |
| 2024-12-09 | Kurtoglu Metin Chief Technology Officer | Sale | −6,224 | $25.26 | $157K | 55,572 |
| 2024-12-09 | Kurtoglu Metin Chief Technology Officer | Sale | −4,539 | $25.83 | $117K | 51,033 |
| 2024-12-09 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −10,763 | 82,000 | ||
| 2024-11-21 | Kurtoglu Metin Chief Technology Officer | Option exercise | +32,789 | $1.41 | $46K | 83,822 |
| 2024-11-21 | Kurtoglu Metin Chief Technology Officer | Sale | −32,789 | $16.67 | $547K | 51,033 |
Page 6 of 16 · 316 trades